Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone.
Maksimovic S, Boscolo NC, La Posta L, Barrios S, Moussa MJ, Gentile E, Pesquera PI, Li W, Chen J, Gomez JA, Basi A, Burks JK, Alvarez-Breckenridge C, Gao J, Campbell MT, Dondossola E.
Maksimovic S, et al. Among authors: chen j.
Cancer Res Commun. 2024 Oct 1;4(10):2621-2637. doi: 10.1158/2767-9764.CRC-24-0304.
Cancer Res Commun. 2024.
PMID: 39248577
Free PMC article.